Keywords: YM BioSciences, Share offering, CYT387, Myeloproliferative disorders, Anemia, Edison Investment Research

Bargaining power boost for YM BioSciences

Article | 05 March 2012

Print This

The share offering last week by Canadian firm biotechnology firm YM BioSciences (TSX: YM), which raised $80.5 million for the company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in